Rapid developments in healthcare technology, combined with improved data collection, pandemic pressures and increased consumer demand for tech-enabled and virtual health care, are fueling innovation and transformation in the digital health space.
The second part of this two-article series on digital therapeutics (DTx) sheds light on challenges faced by the companies in the DTx market and outlines hurdles that must be overcome to achieve success.
There is significant opportunity to develop therapies that create new standards of care and initiate a new wave of precision medicine.
Unauthorized access could allow an attacker to take full control of the host operating system.
Fueled by the need to provide quality care during a global pandemic, healthcare stakeholders are acting quickly to identify new opportunities and overcome challenges.
The more healthcare professionals know about the benefits of digital health, the more they can leverage it to improve their patients’ experiences and remain resilient in an increasingly competitive space.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
The mHealth industry is rapidly disrupting traditional healthcare delivery by leveraging the power of mobile communication technologies and wearable devices.
Investment in new health-related technologies has been greatly accelerated by the pandemic.
Increased awareness during the COVID-19 crisis and public efforts to strengthen the development of healthcare technologies has boosted the smart medical devices sector.